Abstract Aims-To demonstrate Epstein-Barrvirus (EBV) encoded nuclear antigen 1 (EBNA-1) gene expression in EBV associated disorders using a new monoclonal antibody (1H4-1) on routinely processed tissues. Methods-The pressure cooker antigen retrieval method was used for the immunohistochemical demonstration of EBNA-1 gene expression in formalin fixed, EBV positive tissues from Hodgkin's disease, infectious mononucleosis, HIV associated non-Hodgkin's lymphomas, post-transplant lymphomas, and undifferentiated nasopharyngeal carcinoma (NPC). EBV encoded EBNA-2, latent membrane protein 1 (LMP-1) and BZLF-1 gene expression was also examined using commercially available monoclonal antibodies. (_T Clin Pathol 1995;48:845-848) 
Epstein-Barr virus (EBV), a lymphotropic herpesvirus, continues to attract considerable attention and with some justification. The virus is known to be the causative agent of infectious mononucleosis' and has been implicated in an increasing range of human lymphoepithelial disorders, including Burkitt's lymphoma, nasopharyngeal carcinoma, post-transplant lymphoproliferations, oral hairy leucoplakia, HIV related lymphomas, Hodgkin's disease, and T cell lymphomas.2" If the mechanism(s) by which EBV causes malignant transformation is elucidated, the possibility of preventing some of these malignant disorders could become a reality.
EBV is a ubiquitous DNA virus, carried asymptomatically by over 90% of individuals world wide. In vivo, the virus infects B lymphocytes and oropharyngeal epithelial cells. Infection of B cells is mediated by the binding of EBVto the cellular 145 kDa glycoprotein CD2 1, which acts as the viral receptor. 7 In B lymphocytes the virus is thought to restrict its gene expression to EB nuclear antigen 1 (EBNA-1) and EB encoded RNAs (EBERs) only.8 This pattern of gene expression, referred to as latency type I, is probably a strategy adopted by the virus in order to escape immune surveillance. Hodgkin's disease and NPC cases have been included in our previous studies.2"26 Namalwa, B95-8 and an EBV transformed lymphoblastoid cell line were used as EBV positive controls. The Ramos cell line and five cases of reactive lymph nodes were used as negative controls.
EBER ISH AND IMMUNOHISTOCHEMISTRY EBER ISH was carried out as described in detail elsewhere. 24 The recently described pressure cooker antigen retrieval method was used as an adjunct to immunohistochemistry."7 Briefly, 5 jtm paraffin wax sections were dewaxed, endogenous peroxidase activity blocked in H2O2/methanol and then transferred to boiling 0 01 M sodium citrate solution (pH 60) in a pressure cooker. The lid was secured and the pressure allowed to build up. The sections were treated for two minutes at maximum pressure. After rinsing in phosphate buffered saline, the sections were stained using the Vector "elite" Streptavidin-biotin peroxidase complex kit (Vector Laboratories, Peterborough, UK). The following primary monoclonal antibodies were used: CS1-4 (anti-LMP-1), PE2 (anti-EBNA-2), and BZ1 (anti-BZLF-1). All three clones were of mouse IgGl subtype and were used at a 1 in 20 dilution (Dako, High Wycombe, UK). EBNA-1 was detected using clone 1H4-1 (rat IgG) undiluted to a 1 in 10 dilution (kindly provided by Dr Friedrich Grasser, Institut fur Medizinsche Mikrobiologie und Hygiene, Universitatskliniken des Saarlandes, Homburg, Germany). these cases. Fifteen of the 34 EBER and LMP-1 positive cases were also examined for EBNA-2 and BZLF-1 expression, but were negative for both (table) . Of the five EBER positive cases of NPC, none were found to express LMP-1, EBNA-2 or BZLF-1, but all five expressed EBNA-1 (fig 1 B) . By contrast, the five cases of HIV related non-Hodgkin's lymphoma, three cases of infectious mononucleosis and the single case of post-transplant lymphoma examined expressed high levels of LMP-1, EBNA-1, EBNA-2, and BZLF-1 ( fig 1C,  fig 2) . The proportion of cells expressing these proteins, however, varied from case to case. EBNA-1 and EBNA-2 expression was most widespread, while BZLF-1 expression was generally seen in less than 5% of the EBER positive cells. In one case of HIV associated non-Hodgkin's lymphoma, however, more than 75% of the EBNA-1 positive cells expressed BZLF-1, but less than 10% of the EBNA-1 positive
Results

CELL LINES
Initially, cytospins of the B95-8 (EBV+) cell line were used as a positive control for the determination of EBV gene expression. Most of the cells expressed EBERs, EBNA-1 and EBNA-2. LMP-1 staining was observed in less than half of the cells and was most evident in the large binucleated cells. BZLF-1 expression, although very strong, was noted in less than 10% of the cells. Similar results were obtained when formalin fixed, paraffin wax embedded B95-8 cells were used with the pressure cooker method. Interestingly, the 1H4-1 (EBNA-1), PE2 (EBNA-2) and BZ1 (BZLF-1) clones do not work on formalin fixed material in standard immunostaining procedures; after treatment in a pressure cooker, however, strong nuclear staining was seen with all three antibodies. Strong staining with these antibodies was also seen in the EBV transformed lymphoblastoid cell line. Five cases of reactive lymph nodes used as EBV negative controls did not stain with any of these antibodies. (fig 1A) . However, strong cytoplasmic and membrane staining for LMP-1 was seen in all cases. Interestingly, EBNA-1 staining in occasional small lymphocytes was observed in most of . Hence, a negative ER expression and )ted. This is in agreethat EBERs are not y infected (BZLF-1 that LMP-1 is partly responsible for the morphological appearances of binucleated ReedStemnberg-like cells which are frequently seen in many EBV associated lymphoproliferative conditions.517 BZLF-1 staining was Discussion in contrast to cyto-EBV is among the best recognised DNA viruses ining seen for LMP-1 implicated in human malignancies. In recent MP-1 staining was years the widespread availability of reagents Lmunoblasts and bi-such as EBV specific probes and monoclonal tion was best seen in antibodies has allowed investigators to detect acleosis. It is possible and analyse EBV infection at the cellular level.'0
The determination ofEBV gene expression and the role of the viral proteins in the pathogenesis of EBV associated disorders are currently being unravelled. The latent proteins LMP-1 and EBNA-2 have been known for many years to be necessary for cell transformation, but more recently it has been demonstrated that EBNA-1 and EBNA-3A and -3C may also be essential for this process." 18931
The hypothesis that EBNA-1 has oncogenic potential is intriguing. This nuclear phosphoprotein is thought to be the only viral protein consistently expressed in all EBV infected cells. 20 Moreover, this is the only viral protein known to be expressed in Burkitt's lymphoma.9 EBNA-1 has been shown to be a DNA binding protein essential for both viral replication and episome maintenance.3' It binds to DNA as a homodimer at three different sites in the EBV genome, two of which are located in the oriP region.33 Recently, it has been shown that EBNA-1 can also bind to several different species of RNA, including the EBV encoded RNA polymerase III transcript (EBER-1).34 Most of the functional activities of EBNA-1 have been localised to the C terminus of the protein. 2034 Together, all these findings highlight the importance ofEBNA-1 in EBV replication, persistence and cell transformation. Thus, this protein is thought to be essential for EBV survival.
The availability of a monoclonal antibody to EBNA-1 that is effective in routine formalin fixed, paraffin wax embedded tissues prompted us to examine the expression of In conclusion, we report that EBNA-1 is not expressed in EBV infected Reed-Stemnberg cells in Hodgkin's disease. This findinghas important implications for the generally held hypothesis that EBNA-1 is universally expressed in EBV infected cells and that it is essential for EBV replication and episomal maintenance. The possibility that EBNA-1 is expressed in ReedSternberg cells, but at a very low level and below the detection limit of current immunohistochemical methods cannot be ruled out. Alternatively, it is also possible that a mutated form ofEBNA-1 is expressed in Reed-Stemnberg cells which is not recognised by 1 H4-1.
